Prof Johan Hyllner of UK Cell and Gene Therapy Catapult: ‘Leading Innovation in Cell and Gene Therapy’

AUTOSTEM partner, Professor Johan Hyllner Chief Scientific Officer at the UK Cell and Gene Therapy Catapult, presented at the Regenerative Medicine Institute at the National University of Ireland, Galway on 19 September 2017. Prof Hyllner’s talk entitled ‘Leading Innovation in Cell and Gene Therapy’ was introduced by Prof Frank Barry.

AUTOSTEM will present at EU-MSC2 meeting in Leiden

Hosted by Leiden University Medical Center, the EU MSC2 2017 meeting in Leiden, NL on September 12th and 13th will assemble twelve EU-funded, mesenchymal stromal cell-focussed consortia. Projects to be presented include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2, AUTOSTEM, BOOSTB4, SEPCELL, RESSTORE, and RESPINE. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden. Three overarching[…]

TERMIS Meeting Davos, Switzerland

Several members of the Autostem team attended at, and contributed to, the European Chapter Meeting of TERMIS (the Tissue Engineering and Regenerative Medicine International Society) held in Davos, Switzerland on 26-30 June 2017. Autostem Coordinator Dr Mary Murphy (NUIG) presented at the Symposium on Stem Cells for Bone Regeneration. Dr Murphy’s paper was entitled “Assessment[…]

Autostem at Phacilitate Automation Special Interest Group Event

Several partners from Autostem contributed to the Phacilitate Automation Special Interest Group Conference (with a focus on cell and gene therapy), held in Edinburgh on 30/31 May 2017. The event was designed to bring together stakeholders in cell & gene therapy manufacturing and targeted industry, researchers, decision makers, bioprocess developers and engineers working on sourcing, selecting[…]